Psomagen, Inc. (KOSDAQ:950200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,575.00
-40.00 (-1.11%)
At close: Mar 27, 2025, 3:30 PM KST
-32.55%
Market Cap 66.75B
Revenue (ttm) 38.14B
Net Income (ttm) -6.04B
Shares Out 19.24M
EPS (ttm) -345.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,814
Average Volume 16,351
Open 3,615.00
Previous Close 3,615.00
Day's Range 3,525.00 - 3,615.00
52-Week Range 3,505.00 - 6,700.00
Beta 0.10
RSI 26.53
Earnings Date Mar 21, 2025

About Psomagen

Psomagen, Inc. engages in the provision omics solutions and contract laboratory services. The company’s research services comprises of genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; single-cell analysis, research in suspensions, biological fluids, tissues, or cell populations; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its express... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Employees 89
Stock Exchange KOSDAQ
Ticker Symbol 950200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.